26.54

0.68% 0.1791

Harmony Biosciences Holdings Inc (HRMY)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HRMY? Forum Prognose

Schlusskurs vom Vortag:

$26.36

Offen:

$26.36

24-Stunden-Volumen:

222.28K

Relative Volume:

0.29

Marktkapitalisierung:

$1.53B

Einnahmen:

$681.88M

Nettoeinkommen (Verlust:

$122.63M

KGV:

12.58

EPS:

2.11

Netto-Cashflow:

$220.18M

1W Leistung:

-1.89%

1M Leistung:

-18.06%

6M Leistung:

-10.13%

1J Leistung:

-25.20%

1-Tages-Spanne:

$26.21

$26.60

1-Wochen-Bereich:

$25.95

$27.22

52-Wochen-Spanne:

$25.95

$41.61

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Firmenname

Harmony Biosciences Holdings Inc

Sektor

Healthcare (1146)

Branche

Biotechnology (639)

Telefon

(484) 539-9800

Adresse

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Mitarbeiter

268

Twitter

Nächster Verdiensttermin

2024-10-29

Neueste SEC-Einreichungen

HRMY's Discussions on Twitter

Vergleichen Sie HRMY mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HRMY Harmony Biosciences Holdings Inc	26.54	1.52B	681.88M	122.63M	220.18M	2.11
VRTX Vertex Pharmaceuticals Inc	411.02	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	474.85	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.33	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	799.88	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.43	35.92B	4.56B	-176.77M	225.30M	-1.7177

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-21	Eingeleitet	Truist	Buy
2025-07-10	Fortgesetzt	Goldman	Neutral
2025-06-02	Fortgesetzt	Oppenheimer	Outperform
2025-02-11	Eingeleitet	Deutsche Bank	Buy
2024-12-17	Eingeleitet	H.C. Wainwright	Buy
2024-10-10	Fortgesetzt	Raymond James	Outperform
2024-09-10	Eingeleitet	UBS	Buy
2024-06-21	Eingeleitet	Citigroup	Buy
2024-01-02	Herabstufung	BofA Securities	Neutral → Underperform
2023-09-25	Herabstufung	Goldman	Neutral → Sell
2023-09-07	Eingeleitet	Berenberg	Buy
2023-04-20	Eingeleitet	BofA Securities	Neutral
2022-10-14	Hochstufung	Janney	Neutral → Buy
2022-10-14	Hochstufung	Jefferies	Hold → Buy
2022-08-03	Herabstufung	Jefferies	Buy → Hold
2022-07-13	Herabstufung	Goldman	Buy → Neutral
2022-07-07	Eingeleitet	Mizuho	Buy
2022-04-14	Eingeleitet	Cantor Fitzgerald	Overweight
2021-12-01	Eingeleitet	Oppenheimer	Outperform
2021-11-04	Eingeleitet	Raymond James	Outperform
2021-09-23	Eingeleitet	Needham	Buy
2021-03-29	Hochstufung	Goldman	Neutral → Buy
2020-09-14	Eingeleitet	Goldman	Neutral
2020-09-14	Eingeleitet	Jefferies	Buy
2020-09-14	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten

05:35 AM

Long term hold vs stop loss in Harmony Biosciences Holdings Inc.2025 Geopolitical Influence & Daily Chart Pattern Signals - newser.com

05:35 AM

05:19 AM

Harmony Biosciences Holdings Inc. stock trend outlook and recovery pathWeekly Trend Recap & Smart Money Movement Tracker - newser.com

05:19 AM

Oct 13, 2025

What Wall Street predicts for Harmony Biosciences Holdings Inc. stock priceWeekly Gains Report & Smart Swing Trading Techniques - newser.com

Oct 13, 2025

Custom watchlist performance reports with Harmony Biosciences Holdings Inc.2025 Market Sentiment & AI Optimized Trade Strategies - newser.com

Oct 13, 2025

Published on: 2025-10-13 07:02:21 - newser.com

Oct 13, 2025

Oct 12, 2025

Harmony Biosciences Hits 52-Week Low at $26.15 Amid Market Turbulence - Markets Mojo

Oct 12, 2025

Oct 11, 2025

Harmony Biosciences Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo

Oct 11, 2025

Harmony Biosciences (NASDAQ:HRMY) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Oct 11, 2025

Oct 10, 2025

Harmony Biosciences Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Oct 10, 2025

Does Harmony Biosciences Holdings Inc. show high probability of reboundGlobal Markets & Technical Buy Zone Confirmations - newser.com

Oct 10, 2025

Can Harmony Biosciences Holdings Inc. hit a new high this monthJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com

Oct 10, 2025

Using AI based signals to follow Harmony Biosciences Holdings Inc.July 2025 News Drivers & Daily Technical Forecast Reports - newser.com

Oct 10, 2025

Oct 08, 2025

Harmony Biosciences stock hits 52-week low at $26.26 By Investing.com - Investing.com Nigeria

Oct 08, 2025

What analysts say about Harmony Biosciences Holdings Inc stockEarnings Volatility Patterns & Amplify Gains With Picks - earlytimes.in

Oct 08, 2025

Harmony Biosciences (NASDAQ:HRMY) Hits New 1-Year LowWhat's Next? - MarketBeat

Oct 08, 2025

Robeco Institutional Asset Management B.V. Takes $1.48 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Oct 08, 2025

Oct 07, 2025

Top 3 Health Care Stocks That Are Preparing To Pump In Q4 - Sahm

Oct 07, 2025

Oct 06, 2025

Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now? - MSN

Oct 06, 2025

Oct 05, 2025

Using Bollinger Bands to evaluate Harmony Biosciences Holdings Inc.Weekly Trade Report & Weekly Breakout Watchlists - newser.com

Oct 05, 2025

Understanding Harmony Biosciences Holdings Inc.’s price movementOil Prices & Low Drawdown Investment Strategies - newser.com

Oct 05, 2025

What drives Harmony Biosciences Holdings Inc stock priceSector Leadership Analysis & Master Stock Selection - earlytimes.in

Oct 05, 2025

Oct 04, 2025

Harmony Biosciences’ Fragile X Trial Falls Short but Offers Key Insights - MyChesCo

Oct 04, 2025

Oct 03, 2025

Exit strategy if you’re trapped in Harmony Biosciences Holdings Inc.July 2025 Trends & Stock Portfolio Risk Management - newser.com

Oct 03, 2025

Oct 02, 2025

Harmony Biosciences Hits New 52-Week Low at $26.26 - Markets Mojo

Oct 02, 2025

Harmony Biosciences (HRMY): Assessing Valuation After RECONNECT Trial Disappointment for ZYN002 in Fragile X Syndrome - Yahoo Finance

Oct 02, 2025

Oct 01, 2025

H.C. Wainwright Reaffirms Buy on Harmony Biosciences Holdings, Inc. (HRMY) Despite Phase 3 Setback - MSN

Oct 01, 2025

Sep 30, 2025